60

Beihai Gofar Chuanshan Biological Co LtdSHG 600538 Stock Report

Last reporting period 30 Sep, 2023

Updated 18 Oct, 2024

Last price

Market cap $B

0.249

Micro

Exchange

XSHG - Shanghai Stock Exchange

600538.SS Stock Analysis

60

Uncovered

Beihai Gofar Chuanshan Biological Co Ltd is uncovered by Eyestock quantitative analysis.

Rating

To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.

19/100

Low score

Market cap $B

0.249

Dividend yield

Shares outstanding

524.2 B

Beihai Gofar Chuanshan Biological Co., Ltd. The company is headquartered in Beihai, Guangxi and currently employs 425 full-time employees. The company went IPO on 2003-01-14. The firm is mainly engaged in the Pharmaceutical Distribution segment, the Pharmaceutical Manufacturing segment, the Deoxyribonucleic Acid Identification and Service segment, and the Other segment. The firm is mainly engaged in pharmaceutical manufacturing and pharmaceutical distribution industries, molecular medical imaging centers, tumor radiotherapy centers, and tumor telemedicine technical services, molecular diagnostics and judicial identification technical services. The firm mainly sells its products in the domestic market.

View Section: Eyestock Rating